Literature DB >> 23966758

Decision Analysis and Cost-effectiveness Analysis.

Hilary F Ryder, Christine McDonough, Anna N A Tosteson, Jon D Lurie.   

Abstract

Healthcare decision-making can be complex, often requiring decision makers to weigh serious trade-offs, consider patients' values, and incorporate evidence in the face of uncertainty. Medical decisions are made implicitly by clinicians and other decision-makers on a daily basis. Decisions based largely on personal experience are subject to many biases. Decision analysis and cost-effectiveness analysis are systematic approaches used to support decision-making under conditions of uncertainty that involve important trade-offs. These mathematical tools can provide patients, physicians and policy makers with a useful approach to complex medical decision making.

Entities:  

Year:  2009        PMID: 23966758      PMCID: PMC3746772          DOI: 10.1053/j.semss.2009.08.003

Source DB:  PubMed          Journal:  Semin Spine Surg        ISSN: 1040-7383


  35 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  Cost effectiveness analysis in health care: contraindications.

Authors:  Cam Donaldson; Gillian Currie; Craig Mitton
Journal:  BMJ       Date:  2002-10-19

Review 3.  Multi-attribute preference functions. Health Utilities Index.

Authors:  G W Torrance; W Furlong; D Feeny; M Boyle
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

Review 4.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

5.  Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial.

Authors:  James N Weinstein; Tor D Tosteson; Jon D Lurie; Anna N A Tosteson; Brett Hanscom; Jonathan S Skinner; William A Abdu; Alan S Hilibrand; Scott D Boden; Richard A Deyo
Journal:  JAMA       Date:  2006-11-22       Impact factor: 56.272

6.  What will it take to make cost-effectiveness analysis acceptable in the United States?

Authors:  Bryan R Luce
Journal:  Med Care       Date:  2005-07       Impact factor: 2.983

Review 7.  Is there a case for using visual analogue scale valuations in cost-utility analysis?

Authors:  David Parkin; Nancy Devlin
Journal:  Health Econ       Date:  2006-07       Impact factor: 3.046

8.  The journal's policy on cost-effectiveness analyses.

Authors:  J P Kassirer; M Angell
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

Review 9.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Authors:  M C Weinstein; J E Siegel; M R Gold; M S Kamlet; L B Russell
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

10.  The cost-utility of lumbar disc herniation surgery.

Authors:  Elisabeth Hansson; Tommy Hansson
Journal:  Eur Spine J       Date:  2006-05-09       Impact factor: 3.134

View more
  14 in total

1.  Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.

Authors:  Marlon P Mundt; Timothy B Baker; David L Fraser; Stevens S Smith; Megan E Piper; Michael C Fiore
Journal:  Value Health       Date:  2018-09-20       Impact factor: 5.725

2.  Financial incentives to Medicaid smokers for engaging tobacco quit line treatment: maximising return on investment.

Authors:  Marlon P Mundt; Timothy B Baker; Megan E Piper; Stevens S Smith; David L Fraser; Michael C Fiore
Journal:  Tob Control       Date:  2019-05-30       Impact factor: 7.552

3.  Bisphosphonate holidays: using cost-effectiveness analysis for the "yes, but" questions.

Authors:  C S Colón-Emeric; R H Lee
Journal:  Osteoporos Int       Date:  2021-09-13       Impact factor: 4.507

4.  Cost-effectiveness of stop smoking incentives for medicaid-enrolled pregnant women.

Authors:  Marlon P Mundt; Michael C Fiore; Megan E Piper; Robert T Adsit; Kathleen H Kobinsky; Kristine M Alaniz; Timothy B Baker
Journal:  Prev Med       Date:  2021-08-25       Impact factor: 4.018

5.  A Framework that Considers the Impacts of Time, Cost, and Uncertainty in the Determination of the Cost Effectiveness of Toxicity-Testing Methodologies.

Authors:  Paul S Price; Bryan J Hubbell; Shintaro Hagiwara; Greg M Paoli; Daniel Krewski; Annette Guiseppi-Elie; Maureen R Gwinn; Norman L Adkins; Russell S Thomas
Journal:  Risk Anal       Date:  2021-09-07       Impact factor: 4.302

6.  Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.

Authors:  Steven L Morrison; Dmitry Dukhovny; R V Paul Chan; Michael F Chiang; J Peter Campbell
Journal:  JAMA Ophthalmol       Date:  2022-04-01       Impact factor: 8.253

7.  Predicting Therapy Success and Costs for Personalized Treatment Recommendations Using Baseline Characteristics: Data-Driven Analysis.

Authors:  Vincent Bremer; Dennis Becker; Spyros Kolovos; Burkhardt Funk; Ward van Breda; Mark Hoogendoorn; Heleen Riper
Journal:  J Med Internet Res       Date:  2018-08-21       Impact factor: 5.428

8.  Health State Utilities in Children and Adolescents With Osteochondritis Dissecans of the Knee.

Authors:  Joshua Adjei; Benedict U Nwachukwu; Yi Zhang; Huong T Do; Daniel W Green; Emily R Dodwell; Peter D Fabricant
Journal:  Orthop J Sports Med       Date:  2019-12-05

9.  Antiepileptic drug treatment after an unprovoked first seizure: A decision analysis.

Authors:  Erik L Bao; Ling-Ya Chao; Peiyun Ni; Lidia M V R Moura; Andrew J Cole; Sydney S Cash; Daniel B Hoch; Matt T Bianchi; M Brandon Westover
Journal:  Neurology       Date:  2018-09-12       Impact factor: 11.800

10.  Cost-effectiveness analysis of VECTOS software for the control of diseases transmitted by Aedes aegypti in two Colombian municipalities

Authors:  Manuel Alejandro Salinas; Victoria Eugenia Soto; Sergio Iván Prada
Journal:  Biomedica       Date:  2020-06-15       Impact factor: 0.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.